简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-11-21 14:59 Monrol and FutureChem Announced a Clinical Supply Partnership
2022-11-21 09:35 Phase 3 Trial of ICLUSIG® (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US
2022-11-18 22:23 DEXLEVO at AMWC JAPAN: a Successful Debut
2022-11-18 22:20 The New England Journal of Medicine and NEJM Group partner with Wolters Kluwer to expand global reach of leading journals
2022-11-18 22:10 Neuraptive Therapeutics, Inc. Announces Appointment of Leading Industry Executive, Dr. Robert R. Ruffolo as New Director to the Board
2022-11-18 09:37 GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity
2022-11-17 15:11 Exscientia Business and Financial Update for the Third Quarter 2022
2022-11-16 19:49 Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
2022-11-15 15:29 Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in Developing Novel Oncology Treatments
2022-11-15 14:01 World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
2022-11-14 19:16 Pivot Bio Joins AIM for Climate as Innovation Sprint Partner
2022-11-14 10:23 Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
2022-11-14 10:03 Ur24Technology Launches New and Unique ‘TrueClr’ External Catheter Line
2022-11-11 19:19 Esri Enters into Agreement with United Nations Population Fund to Help Modernize National Statistics Programs
2022-11-11 15:17 European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Infection And/or Disease That Are Refractory (With or Without Resistance) to One or More Prior Therapies
2022-11-09 19:36 Citizens Companies Launch Their New Energy Transition Initiative, Supercool Electric Mobility Centers, at COP27 with 60 Locations Expected By 2030.
2022-11-09 15:59 LevitasBio Completes Series C Financing
2022-11-09 14:43 Exscientia to Report Third Quarter 2022 Financial Results on November 15, 2022
2022-11-08 18:10 30 Finalists announced for Zayed Sustainability Prize 2023
2022-11-07 13:35 SINOVAC Varicella Vaccine Prequalified by WHO

Business Wire Weibo

Press Releases

Latest Releases